Association Between Remnant Cholesterol and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis

被引:0
|
作者
Tang, Jiake [1 ]
Tang, Ting [1 ]
Yu, Qingwen [1 ]
Tong, Xuhan [1 ]
Liu, Chun [1 ]
Chen, Chen [1 ]
Hu, Siqi [1 ]
Zhang, Shenghui [1 ]
You, Yao [1 ]
Wang, Chunyi [1 ]
Li, Jie [1 ]
Wen, Wen [2 ]
Chen, Juan [1 ]
Zhang, Xingwei [1 ]
Wang, Mingwei [1 ,3 ]
Tong, Fan [1 ]
机构
[1] Hangzhou Normal Univ, Hangzhou Inst Cardiovasc Dis, Zhejiang Key Lab Med Epigenet,Affiliated Hosp,Dept, Zhejiang Key Lab Res Assessment Cognit Impairments, Hangzhou 310015, Peoples R China
[2] Huzhou Univ, Huzhou Cent Hosp, Affiliated Cent Hosp, Dept Cardiol, Huzhou, Zhejiang, Peoples R China
[3] Hangzhou Linan Fourth Peoples Hosp, Hangzhou, Peoples R China
关键词
nonalcoholic fatty liver disease; remnant cholesterol; meta-analysis; systemic review; low-density lipoprotein cholesterol; DENSITY-LIPOPROTEIN CHOLESTEROL; ISCHEMIC-HEART-DISEASE; STEATOHEPATITIS; DYSFUNCTION; LIPASE; LDL;
D O I
10.1089/met.2024.0042
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lipid disorders are related to the risk of nonalcoholic fatty liver disease (NAFLD). Remnant cholesterol (RC), a nonclassical and once-neglected risk factor for NAFLD, has recently received new attention. In this study, we assessed the relationship between the RC levels and NAFLD risk. We searched across PubMed, Web of Science, Embase, Cochrane Library, and China National Knowledge Infrastructure, with no restrictions on publication languages. Retrospective cohort studies and cross-sectional studies were enrolled from the inception of the databases until August 6, 2023. A random-effect model was applied to construct the mean difference, and a 95% confidence interval was applied to assess the relationship between the RC levels and NAFLD risk. We used two methods to estimate RC levels: Calculated-1 subtracts low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol from total cholesterol; Calculated-2 uses the Friedewald formula for LDL-C when triglycerides are <4.0 mmol/L, otherwise directly measured. A total of 265 published studies were selected through preliminary retrieval. Of these, six studies met the inclusion requirements and were enrolled in the meta-analysis. The RC level in the NAFLD group was significantly higher than that in the non-NAFLD group (mean difference: 0.18, 95% confidence interval: 0.10-0.26, P < 0.00001). We conducted subgroup analyses of computational methods and geographic regions. Notably, in the subgroup analysis of Calculation Method 2, the NAFLD group had significantly higher RC levels than the non-NAFLD group. On the other hand, in Calculation Method 1, the difference between the two groups was insignificant. In both the Asian and non-Asian populations, the RC levels were significantly higher in the NAFLD group than in the non-NAFLD group. The association of RC with an increased NAFLD risk was not dependent on the triglyceride. This meta-analysis suggests that elevated RC levels are associated with an increased risk of NAFLD. In addition to the conventional risk factors for fatty liver, clinicians should be concerned about the RC levels in the clinic.
引用
收藏
页码:637 / 645
页数:9
相关论文
共 50 条
  • [41] The relationship between nonalcoholic fatty liver disease and frailty: A systematic review and meta-analysis
    Khanmohammadi, Shaghayegh
    Masrour, Mahdi
    Fallahtafti, Parisa
    Habibzadeh, Amirhossein
    Schuermans, Art
    Kuchay, Mohammad Shafi
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2025, 19 (02)
  • [42] ASSOCIATIONS BETWEEN REMNANT LIPOPROTEIN CHOLESTEROL AND NONALCOHOLIC FATTY LIVER DISEASE IN ADOLESCENTS
    Ayonrinde, Oyekoya Taiwo
    Chin, Justin
    Mori, Trevor
    Olynyk, John K.
    Beilin, Lawrence
    Adams, Leon A.
    HEPATOLOGY, 2019, 70 : 1070A - 1071A
  • [43] Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis
    Yang, Xiu Hong
    Zhang, Bao Long
    Cheng, Yun
    Fu, Shun Kun
    Jin, Hui Min
    ATHEROSCLEROSIS, 2023, 371 : 21 - 31
  • [44] Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis
    Bonci, Enea
    Chiesa, Claudio
    Versacci, Paolo
    Anania, Caterina
    Silvestri, Lucia
    Pacifico, Lucia
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [45] Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis
    Kong, Tingting
    Gu, Yunpeng
    Sun, Lei
    Zhou, Run
    Li, Jie
    Shi, Junping
    ENDOCRINE JOURNAL, 2023, 70 (10) : 959 - 967
  • [46] Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis
    Wijarnpreecha, Karn
    Thongprayoon, Charat
    Boonpheng, Boonphiphop
    Panjawatanan, Panadeekarn
    Sharma, Konika
    Ungprasert, Patompong
    Pungpapong, Surakit
    Cheungpasitporn, Wisit
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (09) : 986 - 994
  • [47] Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis
    Borges-Canha, Marta
    Neves, Joao Sergio
    Libanio, Diogo
    Von-Hafe, Madalena
    Vale, Catarina
    Araujo-Martins, Miguel
    Leite, Ana Rita
    Pimentel-Nunes, Pedro
    Carvalho, Davide
    Leite-Moreira, Adelino
    ENDOCRINE, 2019, 66 (03) : 467 - 476
  • [48] HFE AND NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hernaez, Ruben
    Yeung, Edwina
    Clark, Jeanne M.
    Kowdley, Kris V.
    Brancati, Frederick L.
    Kao, Wen Hong L.
    HEPATOLOGY, 2009, 50 (04) : 781A - 781A
  • [49] Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis
    Upala, Sikarin
    Jaruvongvanich, Veeravich
    Wijarnpreecha, Karn
    Sanguankeo, Anawin
    JOURNAL OF BONE AND MINERAL METABOLISM, 2017, 35 (06) : 685 - 693
  • [50] Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis
    Sikarin Upala
    Veeravich Jaruvongvanich
    Karn Wijarnpreecha
    Anawin Sanguankeo
    Journal of Bone and Mineral Metabolism, 2017, 35 : 685 - 693